These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 19075186)
1. Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. Gordon WR; Roy M; Vardar-Ulu D; Garfinkel M; Mansour MR; Aster JC; Blacklow SC Blood; 2009 Apr; 113(18):4381-90. PubMed ID: 19075186 [TBL] [Abstract][Full Text] [Related]
2. Effects of S1 cleavage on the structure, surface export, and signaling activity of human Notch1 and Notch2. Gordon WR; Vardar-Ulu D; L'Heureux S; Ashworth T; Malecki MJ; Sanchez-Irizarry C; McArthur DG; Histen G; Mitchell JL; Aster JC; Blacklow SC PLoS One; 2009 Aug; 4(8):e6613. PubMed ID: 19701457 [TBL] [Abstract][Full Text] [Related]
3. Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors. Aste-Amézaga M; Zhang N; Lineberger JE; Arnold BA; Toner TJ; Gu M; Huang L; Vitelli S; Vo KT; Haytko P; Zhao JZ; Baleydier F; L'Heureux S; Wang H; Gordon WR; Thoryk E; Andrawes MB; Tiyanont K; Stegmaier K; Roti G; Ross KN; Franlin LL; Wang H; Wang F; Chastain M; Bett AJ; Audoly LP; Aster JC; Blacklow SC; Huber HE PLoS One; 2010 Feb; 5(2):e9094. PubMed ID: 20161710 [TBL] [Abstract][Full Text] [Related]
4. Force-induced unfolding simulations of the human Notch1 negative regulatory region: possible roles of the heterodimerization domain in mechanosensing. Chen J; Zolkiewska A PLoS One; 2011; 6(7):e22837. PubMed ID: 21829530 [TBL] [Abstract][Full Text] [Related]
5. Direct observation of proteolytic cleavage at the S2 site upon forced unfolding of the Notch negative regulatory region. Stephenson NL; Avis JM Proc Natl Acad Sci U S A; 2012 Oct; 109(41):E2757-65. PubMed ID: 23011796 [TBL] [Abstract][Full Text] [Related]
6. Human NOTCH2 Is Resistant to Ligand-independent Activation by Metalloprotease Adam17. Habets RA; Groot AJ; Yahyanejad S; Tiyanont K; Blacklow SC; Vooijs M J Biol Chem; 2015 Jun; 290(23):14705-16. PubMed ID: 25918160 [TBL] [Abstract][Full Text] [Related]
7. Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes. Malecki MJ; Sanchez-Irizarry C; Mitchell JL; Histen G; Xu ML; Aster JC; Blacklow SC Mol Cell Biol; 2006 Jun; 26(12):4642-51. PubMed ID: 16738328 [TBL] [Abstract][Full Text] [Related]
9. Insights into Autoregulation of Notch3 from Structural and Functional Studies of Its Negative Regulatory Region. Xu X; Choi SH; Hu T; Tiyanont K; Habets R; Groot AJ; Vooijs M; Aster JC; Chopra R; Fryer C; Blacklow SC Structure; 2015 Jul; 23(7):1227-35. PubMed ID: 26051713 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic antibody targeting of individual Notch receptors. Wu Y; Cain-Hom C; Choy L; Hagenbeek TJ; de Leon GP; Chen Y; Finkle D; Venook R; Wu X; Ridgway J; Schahin-Reed D; Dow GJ; Shelton A; Stawicki S; Watts RJ; Zhang J; Choy R; Howard P; Kadyk L; Yan M; Zha J; Callahan CA; Hymowitz SG; Siebel CW Nature; 2010 Apr; 464(7291):1052-7. PubMed ID: 20393564 [TBL] [Abstract][Full Text] [Related]
11. Notch in Leukemia. McCarter AC; Wang Q; Chiang M Adv Exp Med Biol; 2018; 1066():355-394. PubMed ID: 30030836 [TBL] [Abstract][Full Text] [Related]
12. Evidence for increased exposure of the Notch1 metalloprotease cleavage site upon conversion to an activated conformation. Tiyanont K; Wales TE; Aste-Amezaga M; Aster JC; Engen JR; Blacklow SC Structure; 2011 Apr; 19(4):546-54. PubMed ID: 21481777 [TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the Notch2 negative regulatory region identifies key structural elements for mechanical stability. Stephenson NL; Avis JM FEBS Open Bio; 2015; 5():625-33. PubMed ID: 26288744 [TBL] [Abstract][Full Text] [Related]
15. Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1. Ashworth TD; Pear WS; Chiang MY; Blacklow SC; Mastio J; Xu L; Kelliher M; Kastner P; Chan S; Aster JC Blood; 2010 Dec; 116(25):5455-64. PubMed ID: 20852131 [TBL] [Abstract][Full Text] [Related]
16. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia. Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525 [TBL] [Abstract][Full Text] [Related]
17. An activating intragenic deletion in NOTCH1 in human T-ALL. Haydu JE; De Keersmaecker K; Duff MK; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Ferrando A Blood; 2012 May; 119(22):5211-4. PubMed ID: 22510873 [TBL] [Abstract][Full Text] [Related]
18. Two novel protein Takeuchi H; Schneider M; Williamson DB; Ito A; Takeuchi M; Handford PA; Haltiwanger RS Proc Natl Acad Sci U S A; 2018 Sep; 115(36):E8395-E8402. PubMed ID: 30127001 [TBL] [Abstract][Full Text] [Related]
19. Characterization of transgenic mice expressing cancer-associated variants of human NOTCH1. Berquam-Vrieze KE; Swing DA; Tessarollo L; Dupuy AJ Genesis; 2012 Feb; 50(2):112-8. PubMed ID: 21898766 [TBL] [Abstract][Full Text] [Related]